Research Use Only
Semax
CAS #80714-61-0
$45.00
- CAS #
- 80714-61-0
- Suggested Association
- Cognitive enhancement, neurological injury rehabilitation, overall mental resilience
- Indicated Involvement
- Neuronal survival, growth, and differentiation, dopamine and serotonin regulation
Not currently approved for therapeutic use by the FDA
References
- National Institutes of Health (NIH). Peptide research and applications.
- FDA. Drug Approvals and Databases.
- Kryukov, E.V., et al. (2019). Semax as a Novel Neuroprotective Peptide.
- Taranushenko, A.A., et al. (2020). Mechanisms of Action of Semax.